IMPORTANT SAFETY INFORMATION
Do not take AZILECT® (rasagiline tablets) if you are taking meperidine as it could result in a serious reaction such as coma or death. Also, do not take AZILECT with tramadol, methadone, propoxyphene, dextromethorphan, St. John’s wort, or cyclobenzaprine. You also should not take AZILECT with other monoamine oxidase inhibitors (MAOIs), as it could result in an unsafe rise in blood pressure. Read More Important Safety Information
Because Parkinson's is a progressive disease, chances are your medication needs will change over time.
The good news is that AZILECT is an effective add-on therapy to dopamine agonists and levodopa, which are common medications used in Parkinson's disease treatment.
A clinical study showed that when AZILECT is added to a dopamine agonist alone, movement symptoms are improved as measured by a Parkinson's disease scale.
Levodopa is a highly effective treatment, but after a while, patients may notice that its benefits begin to wear off more quickly after taking a dose. That's when other medications, such as AZILECT, can be added to give patients added symptom relief.
Clinical studies have shown that when added to levodopa, AZILECT helps:
And AZILECT has demonstrated tolerability, even if you're an older patient (over 65) and/or taking levodopa.
Finally, AZILECT is a once-daily medication, so it's convenient to add to your current medication schedule.
AZILECT® (rasagiline tablets) is indicated for the treatment of Parkinson’s disease (PD).